Income Statement
BIOMEA FUSION, INC.
BMEA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
83.51 | 144.07 | 126.14 | 83.63 | 41.67 |
|
Research & Development
|
61.98 | 118.09 | 102.55 | 62.71 | 28.00 |
|
Selling, General & Administrative
|
19.33 | 25.99 | 23.59 | 20.92 | 13.67 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-83.51 | -144.07 | -126.14 | -83.63 | -41.67 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-61.80 | -138.43 | -117.26 | -81.83 | -41.57 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-83.51 | -144.07 | -126.14 | -83.63 | -41.67 |
|
Earnings Per Share (Basic)
|
-1.18 | -3.83 | -3.44 | -2.80 | - |
|
Diluted EPS
|
-1.18 | -3.83 | -3.44 | -2.80 | - |
|
Weighted Average Shares
|
52.23 | 36.11 | 34.11 | 29.27 | - |
|
Diluted Weighted Avg Shares
|
52.23 | 36.11 | 34.11 | 29.27 | - |
|
Comprehensive Income
|
-61.80 | -138.43 | -117.25 | -81.82 | -41.58 |